LpxC inhibitors: a patent review (2010-2016)-Reference-Cited by-同舟云学术

LpxC inhibitors: a patent review (2010-2016)

Published:2017-08-04 Issue:11 Volume:27 Page:1227-1250
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Kalinin Dmitrii V.¹²³⁴,Holl Ralph¹²

Affiliation:

1. Institut für Organische Chemie, Universität Hamburg, Hamburg, Germany

2. German Center for Infection Research (DZIF), partner site Hamburg-Lübeck-Borstel-Riems

3. Institut für Pharmazeutische und Medizinische Chemie, Westfälische Wilhelms-Universität Münster, Münster, Germany

4. Cells-in-Motion Cluster of Excellence (EXC 1003 - CiM), University of Münster, Münster, Germany

Funder

Deutsche Forschungsgemeinschaft

Deutsches Zentrum für Infektionsforschung

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2017.1360282

Reference57 articles.

1. The top 10 causes of death. Fact sheet No. 310 [internet]. Geneva: World Health Organization; 2017. cited 2017 July 29. Available from: http://www.who.int/mediacentre/factsheets/fs310/en/.

2. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

3. Initial Emergency Department Diagnosis and Management of Adult Patients with Severe Sepsis and Septic Shock

4. Drug-resistant tuberculosis: time for visionary political leadership

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring marine-derived bioactive compounds for dual inhibition of Pseudomonas aeruginosa LpxA and LpxD: integrated bioinformatics and cheminformatics approaches;Molecular Diversity;2024-05-23

2. Lipase and Protease Production Ability of Multi-drug Resistant Bacteria Worsens the Outcomes of Wound Infections;Current Pharmaceutical Design;2024-05

3. LpxC inhibition: Potential and opportunities with carbohydrate scaffolds;Carbohydrate Research;2024-03

4. Advances in Development of Novel Therapeutic Strategies against Multi-Drug Resistant Pseudomonas aeruginosa;Antibiotics;2024-01-25

5. Novel Hydroxamic Acids Containing Aryl-Substituted 1,2,4- or 1,3,4-Oxadiazole Backbones and an Investigation of Their Antibiotic Potentiation Activity;International Journal of Molecular Sciences;2023-12-20